<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02649738</url>
  </required_header>
  <id_info>
    <org_study_id>CLEI-Tissue-Inlay</org_study_id>
    <nct_id>NCT02649738</nct_id>
  </id_info>
  <brief_title>Corneal Tissue Inlay for Keratoconus</brief_title>
  <official_title>Use of Preserved Corneal Tissue Inlay to Treat Keratoconus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cornea and Laser Eye Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cornea and Laser Eye Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the outcomes of placing preserved corneal tissue within the
      keratoconic cornea in order to enhance thickness, stability, and optical conformation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of this study is to evaluate the outcomes of placing preserved corneal tissue
      within the corneal stroma in keratoconus patients as a means of enhancing thickness,
      stability, and optical conformation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2015</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Corneal tissue inlay for keratoconus</measure>
    <time_frame>6 months</time_frame>
    <description>Change in maximum keratometry on corneal topography</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Corneal tissue inlay for keratoconus</measure>
    <time_frame>6 months</time_frame>
    <description>Uncorrected visual acuity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Corneal tissue inlay for keratoconus</measure>
    <time_frame>6 months</time_frame>
    <description>Best spectacle corrected visual acuity</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Keratoconus</condition>
  <arm_group>
    <arm_group_label>Corneal tissue inlay</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The treated cornea will be implanted with a thin disc of preserved corneal tissue</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Corneal tissue inlay</intervention_name>
    <description>A mid-stomal pocket will be made into the cornea with a femtosecond laser (Intralase). A small disc of preserved corneal tissue will then be placed into the pocket</description>
    <arm_group_label>Corneal tissue inlay</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Be at least 18 years of age, male or female, of any race

          -  Provide written informed consent and sign a HIPAA form

          -  Willingness and ability to follow all instructions and comply with schedule for
             follow-up visits

          -  For females: Must not be pregnant

          -  Having topographic evidence of keratoconus which is graded as moderate or severe
             keratoconus.

        Exclusion Criteria:

          -  Contraindications, sensitivity or known allergy to the use of the test article(s) or
             their components

          -  If female, pregnant

          -  Eyes classified as either normal, atypical normal, keratoconus suspect or mild
             keratoconus on the severity grading scheme

          -  Previous ocular condition (other than refractive error) in the eye to be treated that
             may predispose the eye for future complications For example: a history of corneal
             disease (e.g., herpes simplex, herpes zoster keratitis, corneal melt, corneal
             dystrophy, etc.)

          -  A history of delayed corneal healing in the eye to be treated

          -  Have used an investigational drug or device within 30 days of the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Hersh, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cornea and Laser Eye Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cornea and Laser Eye Institue - Hersh Vision Group</name>
      <address>
        <city>Teaneck</city>
        <state>New Jersey</state>
        <zip>07666</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>BethAnn Furlong-Hibbert, BA</last_name>
      <phone>201-883-0505</phone>
      <email>bfurlong-hibbert@vision-institute.com</email>
    </contact>
    <contact_backup>
      <last_name>Stacey Lazar, BS</last_name>
      <phone>201-883-0505</phone>
      <email>slazar@vision-institute.com</email>
    </contact_backup>
    <investigator>
      <last_name>Peter S Hersh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 6, 2016</study_first_submitted>
  <study_first_submitted_qc>January 6, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 7, 2016</study_first_posted>
  <last_update_submitted>August 24, 2017</last_update_submitted>
  <last_update_submitted_qc>August 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>keratoconus</keyword>
  <keyword>corneal tissue inlay</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratoconus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

